SciTech Development, LLC Announces FDA Acceptance of Investigational New Drug (IND) Application for ST-001 nanoFenretinide in Patients with T-Cell Lymphoma
SciTech Development, LLC Announces FDA Acceptance of Investigational New Drug (IND) Application for ST-001 nanoFenretinide in Patients with T-Cell LymphomaCompany will present at Biotech Showcase™ 2020 on Monday, 01/13/20 at 11:15am PST in San Francisco, CA NEWS PROVIDED BY SciTech Development, LLC 23 Dec, 2019, 09:05 ET GROSSE POINTE FARMS, Mich., Dec. 23, 2019 /PRNewswire/…